THE ROLE OF MATRIX TABLET IN DRUG DELIVERY SYSTEM
DOI:
https://doi.org/10.22159//ijap.2018v10i1.21935Keywords:
Sustained release, Controlled release, Diffusion, Erosion and matrixAbstract
Matrix tablet is an important tool for controlled and sustained release dosage forms. The oral route remains the most common route for the administration of drugs. Tablets offer the lowest cost approach to sustained and controlled release dosage forms. The hydrophilic polymer matrix is widely used in this dosage form. The use of different polymers in controlling the release of drugs has become the most important tool in the formulation of matrix tablets. The drug releases by both dissolution-controlled as well as diffusion-controlled mechanisms from the matrix. The development of oral controlled release systems has been a challenge to formulation scientists due to their inability to restrain and localize the system at targeted areas of the gastrointestinal tract. There are several advantages of matrix devices including improved patient compliance due to less frequent drug administration, reduction of fluctuation in steady-state drug levels, maximum utilization of the drug, increased safety margin of a potent drug. This review aims on the discussion of different materials used to prepare matrix tablets, different types of matrix tablets and the drug release mechanism from the matrices.
Downloads
References
Kumar S, Kumar A, Gupta V, Malodia K, Rakha P. Oral extended release drug delivery system: a promising approach. Asian J Pharm Technol 2012;2:38-43.
Yang Lina S, Kawashimab Y. Current status and approaches to developing press-coated chronodelivery drug systems. J Controlled Release 2012;157:331-53.
Sharma A, Sharma S, Jha KK. The study of salbutamol matrix tablets using different polymers as release retarding agent. Pharma Res 2009;1:15-22.
Mandal UK, Chatterjee B, Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: a recent update. Asian J Pharm Sci 2016;11:575–84.
Das MK, Sahu BP, Hazarika JNR. Development of bilayer tablets for the immediate and controlled release of allicin. Int J Curr Pharm Res 2017;9:153-60.
Ain S, Kumar B, Pathak K. Development and characterization of controlled release famotidine matrix tablets containing complexes. Int J Appl Pharm 2017;9:38-46.
Rajput GC, Majmudar FD, Patel JK, Thakor RS, Patel BP, Rajgor NB. Stomach-specific mucoadhesive microsphere as a controlled drug delivery system. Int J Pharm Biomed Res 2010;1:30-41.
Olivares-Morales A, Kamiyama Y, Darwich AS, Aarons L, Rostami-Hodjegan A. Analysis of the impact of controlled release formulations on oral drug absorption, gut wall metabolism and relative bioavailability of CYP3A substrates using a physiologically-based pharmacokinetic model. Eur J Pharm Sci 2015;67:32-44.
Shin KH, Yoon G, Yoon IS, Park JW. Preparation and evaluation of oral controlled-release cilostazol formulation: pharmacokinetics and antithrombotic efficacy in dogs and healthy male Korean participants. J Pharm Pharmacol 2014;66:961-74.
Neeharika MS, Jyothi BJ. Chronotherapeutics: an optimizing approach to synchronize drug delivery with circadian rhythm. J Crit Rev 2015;2:31-40.
Kubova K, Pecek D, Hasserova K, Dolezel P, Pavelkova M, Vyslouzil J, et al. The influence of thermal treatment and type of insoluble poly (meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis. Pharm Dev Technol 2017;22:206-17.
Jayanthi B, Manna PK, Madhusudhan S, Mohanta GP, Manavalan R. Per oral extended release products-an overview. J Appl Pharm Sci 2011;1:50-5.
Li L, Zhang X, Gu X, Mao S. Applications of natural polymeric materials in solid oral modified-release dosage forms. Curr Pharm Des 2015;21:5854-67.
Agüero L, Zaldivar-Silva D, Peña L, Dias ML. Alginate microparticles as oral colon drug delivery device: a review. Carbohydr Polym 2017;168:32-43.
Semjonov K, Kogermann K, Laidmäe I, Antikainen O, Strachan CJ, Ehlers H, et al. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers. Eur J Pharm Sci 2017;97:237-46.
Zimmer Å, Kasperek R, Poleszak E. Modern polymers in matrix tablets technology. Polim Med 2014;44:189-96.
Chidambaram N, Porter W, Flood K, Qui Y. Formulation and characterisation of new layered diffusional matrices for zero-order sustained release. J Controlled Release 1998;52:149-58.
Zou M, Wang Y, Xu C, Cheng G, Ren J, Wu G. Wax-matrix tablet for time-dependent colon-specific delivery system of sophora flavescens aiton: preparation and in vivo evaluation. Drug Dev Ind Pharm 2009;35:224-33.
Campiñez MD, Aguilar-de-Leyva A, Ferris C, de Paz MV, Galbis JA, Caraballo I. Study of the properties of the new biodegradable polyurethane PU (TEG-HMDI) as matrix forming excipient for controlled drug delivery. Drug Dev Ind Pharm 2013;39:1758-64.
Kanjanabat S, Pongjanyakul T. Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery. AAPS PharmSciTech 2011;12:683-92.
Krajacic AB, Tucker G. Matrix formation in sustained release tablets: possible mechanism of dose dumping. Int J Pharm 2003;251:67-78.
Shaikh HK, Kshirsagar RV, Patil SG. Mathematical models for drug release characterization: a review. World J Pharm Res 2015;4:324-38.
